GEISTLICH PERIO-SYSTEM COMBI-PACK , GEISTLICH BIO-GIDE PERIO

K112575 · Geistlich Pharma AG · NPM · Dec 27, 2011 · Dental

Device Facts

Record IDK112575
Device NameGEISTLICH PERIO-SYSTEM COMBI-PACK , GEISTLICH BIO-GIDE PERIO
ApplicantGeistlich Pharma AG
Product CodeNPM · Dental
Decision DateDec 27, 2011
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3930
Device ClassClass 2
AttributesTherapeutic

Intended Use

Geistlich Bio-Gide® Perio is intended for the following uses: - Augmentation around implants placed in immediate extraction sockets; - Augmentation around implants placed in delayed extraction sockets; - Localized ridge augmentation for later implantation; - Alveolar ridge reconstruction for prosthetic treatment; - Filling of bone defects after root resection, cystectomy, removal of retained teeth; - Guided bone regeneration in dehiscence defects; - Guided tissue regeneration procedures in periodontal defects. Geistlich Bio-Oss Collagen® is intended for the following uses: - Augmentation or reconstructive treatment of the alveolar ridge; - Filling of periodontal defects; - Filling of defects after root resection, apicoectomy, and cystectomy; - Filling of extraction sockets to enhance preservation of the alveolar ridge; - Elevation of the maxillary sinus floor; - Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR); - Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR).

Device Story

Geistlich Perio-System Combi-Pack is a convenience kit containing Geistlich Bio-Oss Collagen (purified cancellous bone mineral granules with 10% collagen) and Geistlich Bio-Gide Perio (bilayer collagen membrane). Used by clinicians in dental/periodontal surgery to facilitate bone regeneration. The membrane features a porous surface for bone cell ingrowth and a dense surface to prevent soft tissue infiltration. The bone graft provides a scaffold for new bone formation. Clinicians trim the membrane using provided sterile templates to fit the specific defect. The kit simplifies the surgical workflow by providing both components together. Benefits include improved clinical attachment levels and probing pocket depths in periodontal defects, as well as successful ridge augmentation and defect filling, supporting long-term prosthetic or implant treatment.

Clinical Evidence

Evidence includes a published nonclinical animal study (rabbit femoral defects) showing histological bone regeneration. Multiple published clinical studies (5-year follow-up) demonstrate improvements in clinical attachment levels and probing pocket depths compared to access flap surgery. Case series provide histological evidence of periodontal regeneration.

Technological Characteristics

Kit contains: 1) Geistlich Bio-Oss Collagen (purified bovine-derived cancellous bone mineral granules + 10% collagen fibers); 2) Geistlich Bio-Gide Perio (bilayer collagen membrane, 16mm x 22mm). Both components are sterilized by gamma irradiation. Membrane is non-cross-linked collagen with a dense, cell-occlusive surface and a porous surface. Includes uncoated Tyvek templates as accessories.

Indications for Use

Indicated for patients requiring alveolar ridge augmentation, reconstruction, or bone defect filling in dental/periodontal procedures, including extraction sockets, root resection, cystectomy, maxillary sinus floor elevation, and peri-implant defects. Used in conjunction with GTR/GBR procedures.

Regulatory Classification

Identification

Bone grafting material is a material such as hydroxyapatite, tricalcium phosphate, polylactic and polyglycolic acids, or collagen, that is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.

Special Controls

*Classification.* (1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval. (c) *Date premarket approval application (PMA) or notice of product development protocol (PDP) is required.* Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K112575 # DEC 2 7 2011 #### 510(k) Summary # GEISTLICH PERIO-SYSTEM COMBI-PACK #### SPONSOR Geistlich Pharma AG Bahnhofstrasse 40 CH-6110 Wolhusen Switzerland | Contact Person: | Daniel Kracov, Arnold & Porter, LLP | |-----------------|-------------------------------------| | e-mail: | Daniel.Kracov@aporter.com | | Phone: | (202)942-5120 | | Date Prepared: | December 13, 2011 | ## DEVICE NAME | Proprietary Name: | Geistlich Perio-System Combi-Pack (containing one<br>unit of Geistlich Bio-Oss Collagen® and one<br>unit of Geistlich Bio-Gide® Perio) | |----------------------|----------------------------------------------------------------------------------------------------------------------------------------| | Common/Usual Names: | Natural Bone Grafting Material Plus Collagen<br>Resorbable Bilayer Membrane for GTR/GBR | | Classification Name: | Bone grafting material, animal source (NPM)<br>Barrier animal source intraoral (NPL) | ## PREDICATE DEVICES Bio-Oss Collagen® (K092428, K033815, K974399) Bio-Gide® (K050446, K042197, K960724) #### DEVICE DESCRIPTION 2. {1}------------------------------------------------ Geistlich Perio-System Combi-Pack is a convenience kit containing one unit of Geistlich Bio-Oss Collagen® and one unit of Geistlich Bio-Gide® Perio. Geistlich Bio-Oss Collagen® (sold either as an individual unit or as one of the components of Geistlich Perio-System Combi-Pack) is a combination of purified spongiosa (cancellous) natural bone mineral granules and 10% collagen fibers in a block form and is sterilized by gamma irradiation. Geistlich Bio-Gide® Perio (sold either as an individual unit or as one of the components of Geistlich Perio-System Combi-Pack) is a pure collagen membrane with a bilayer structure and smoothed dense (cell-occlusive) surface. The modified surface makes the membrane somewhat stiffer in the dry state, and this facilitates cutting the membrane for periodontal applications. The porous surface (facing the bone) allows the ingrowth of bone forming cells, and the dense surface (facing the soft tissue) prevents the ingrowth of fibrous connective tissue into the defect. The membrane is made of collagen without further cross-linking, and is sterilized by gamma irradiation. The size of the Geistlich Bio-Gide® Perio bilayer membrane to be provided in the Geistlich Perio-System Combi-Pack convenience kit and as individual units is 16 mm x 22 mm. Preformed sterile templates are provided to simplify the cutting of the respective membrane shape. Four templates (uncoated Tyvek®) are packaged with Geistlich Bio-Gide® Perio to serve as an aid to assist the clinician in trimming the Geistlich Bio-Gide® Perio membrane to fit the defect, and are in varying shapes to fit the clinical need (e.g., rectangular, interproximal). The templates are packaged as an accessory product with Geistlich Bio-Gide® Perio. #### INTENDED USE Geistlich Bio-Gide® Perio is intended for the following uses: - Augmentation around implants placed in immediate extraction sockets; - Augmentation around implants placed in delayed extraction sockets; - Localized ridge augmentation for later implantation; - Alveolar ridge reconstruction for prosthetic treatment; - Filling of bone defects after root resection, cystectomy, removal of retained teeth; - Guided bone regeneration in dehiscence defects; - Guided tissue regeneration procedures in periodontal defects. Geistlich Bio-Oss Collagen® is intended for the following uses: - Augmentation or reconstructive treatment of the alveolar ridge; {2}------------------------------------------------ - Filling of periodontal defects; - Filling of defects after root resection, apicoectomy, and cystectomy; - Filling of extraction sockets to enhance preservation of the alveolar ridge; - Elevation of the maxillary sinus floor; - Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR); - Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR). The two products are being packaged together as a convenience kit for the ease of clinician use in periodontal regenerative procedures. In addition, Geistlich Bio-Gide® Perio will be packaged and sold as individual units. ## TECHNOLOGICAL CHARACTERISTICS Geistlich Bio-Oss Collagen® and Geistlich Bio-Gide® Perio, the two component devices of Geistlich Perio-System Combi-Pack, have the same technological characteristics (e.g., design, material) and intended use of their respective predicate devices, Bio-Oss Collagen® and Bio-Gide®. ## PERFORMANCE DATA A published nonclinical animal study provides histological evidence that Geistlich Bio-Gide® Perio, in combination with Geistlich Bio-Oss Collagen®, regenerates bone in 5 mm diameter rabbit femoral defects (1). Several published clinical studies demonstrate improvements in clinical attachment levels and probing pocket depths through 5-year follow-up versus the control (access flap surgery) (2,3,4). Histological evaluation of teeth in a case series demonstrated periodontal regeneration (5). The results of these published studies demonstrate the substantial equivalence of Geistlich Bio-Gide® Perio and Geistlich Bio-Oss Collagen® to their respective predicate devices. - Lysiak-Drwal K, Dominiak M, Solski L, Zywicka B, Pielka S, Konopka T, Gerber 1. H. Early histological evaluation of bone defect healing with and without guided {3}------------------------------------------------ bone regeneration techniques: Experimental animal studies. Postepy Hig Med Dosw (online) 2008;62:282-288. - Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M. Healing 2. of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. A controlled study. J Clin Periodontol. 2003;30:73-80, 2003. - Sculean A, Chiantella GC, Windisch P, Arweiler NB, Brecx M, Gera I. Healing of 3. intra-bony defects following treatment with a composite bovine-derived xenograft (Bio-Oss Collagen) in combination with a collagen membrane (Bio-Gide Perio). J Clin Periodontol. 2005;32:720-724. - Sculean A, Schwarz F, Chiantella GC, Donos N, Arweiler NB, Brecx M, Becker J. 4. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR. J Clin Periodontol. 2007;34:72-77. - Sculean A, Stavropoulos A, Windisch P, Keglevich T, Karring T, Gera I. Healing ഗ് of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration. Clin Oral Invest. 2004;8:70-74. {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol with flowing lines, representing human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the symbol. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 DEC 2 7 2011 Geistlich Pharma AG C/O Mr. Daniel A. Kracov Arnold & Porter LLP 555 Twelfth Street, NW Washington, D.C. 20004 Re: K112575 Trade/Device Name: Geistlich Perio-System Combi-Pack Regulation Number: 21 CFR 872.3930 Regulation Name: Bone Grafting Material Regulatory Class: II Product Code: NPM, NPL Dated: December 20, 2011 Received: December 21, 2011 Dear Mr. Kracov: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general approvisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {5}------------------------------------------------ #### Page 2 - Mr. Kracov Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements modi matt 1 Dr. mas made a statutes and regulations administered by other Federal agencies. of the Act of any I vact's requirements, including, but not limited to: registration r ou must compty with and 07); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing (reporting of incurents as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm 1 15809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to Compilance: "Theo, prease not 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the r ou into of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Wh for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health {6}------------------------------------------------ # Indications for Use 510(k) Number (if known): Kl l2 5 7 5 Device Name: Geistlich Perio-System Combi-Pack #### Indications For Use: Geistlich Bio-Gide® Perio is intended for the following uses: Geistlich Dio-Olde - Peno is ants placed in immediate extraction sockets; - Augmentation around implants placed in delayed extraction sockets; - Localized ridge augmentation for later implantation; - Alveolar ridge reconstruction for prosthetic treatment; - Filling of bone defects after for presction, cystectorny, removal of retained teeth; - Guided bone regeneration in dehiscence defects; - Guided bone regeneration procedures in periodontal defects. Geistlich Bio-Oss Collagen® is intended for the following uses: - Augmentation or reconstructive treatment of the alveolar ridge; - Filling of periodontal defects; - Filling of perfodoman dolotter Filling of defects after root resection, apicoectorny, and cystectorny, - Filling of defootballs ansockets to enhance preservation of the alveolar ridge; - Elevation of the maxillary sinus floor; - Elevation of the maxillary sinus noor, - Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR); Guided Bone Regeneration (GBR), - Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR), | Prescription Use | X | |------------------------|---| | (21 CFR 801 Subpart C) | | AND/OR | Over-The-Counter Use | ______ | |-----------------------------|--------| | (Part 21 CFR 801 Subpart D) | | (Please do Not WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) # Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number:
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...